AXXE

 
Common Stock Alternative Reporting
Pink Current Information
Verified Company Profile 1/12/2017
Contact Info
  • 3250 Bloor St.W
  • Suite 600
  • Toronto, ONT M8X 2X9
  • Canada

Business Description


 
Financial Reporting/Disclosure
Reporting Status Alternative Reporting Standard
Audited Financials Unaudited
Latest Report Sep 30, 2016 Quarterly Report
CIK 0001103309
Fiscal Year End 12/31
OTC Marketplace Pink Current
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: NV, USA
Year of Inc. 2012
Employees 4 a/o Sep 24, 2013
Company Officers/Contacts
Daniel Bagi, M.D. President, CEO, IR
Company Directors
Daniel Bagi, M.D.
Service Providers
Accounting/Auditing Firm
KLJ & Associates, LLP
1660 Highway 100 South
Suite 100
St. Louis Park, MN, 55416
United States
 
Securities Counsel
Szaferman Lakind Blumstein & Blader, PC
101 Grovers Mill Road
2nd Floor
Lawrenceville, NJ, 08648
United States
 
Investor Relations Firm

Not Available
Company History
  • Formerly=CGI Communications Services, Inc. until 7-2008
AXXE Security Details
Share Structure
Market Value1 $254,033 a/o Mar 29, 2017
Authorized Shares 3,000,000,000 a/o Sep 30, 2016
Outstanding Shares 2,540,334,588 a/o Dec 23, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value Not Available
Transfer Agent(s)
Corporate Stock Transfer, Inc.
Shareholders
Shareholders of Record Not Available
Short Selling Data
Short Interest 0 (-100%)
Jan 13, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security